Member Info for Vanilla

Exactly I believe the market is significantly undervaluing the Murata & to some extent the Ioxus arrangement. Those murata lines would of cost many more millions and the market they serve is coming to life. To have in-house manufacturing and direct contact with customers is a huge bonus in my opinion and worth more than the current cpx mcap on its own. CPX have also been trying for years to partner with someone to bring to market the large cap modules and now they have a full product range again to serve customers ready to utilise this technology.
Whilst the uptake has been slow as you say things are in place now and moving in the right direction just need the numbers to back-up all the good news and no reason the sp won't be much higher.

You don't really want to go there Mer but they were shipping 3v tech for the coin cell market nearly 5yrs ago, had signed MoU's for automobile applications with trial modules shipping with the expectation of high volume high value orders, truckstart modules, stop start applications, ev motorsport applications, mobile phones, smart credit cards the list goes on but nothing of any significance materialised.
It's only now the prismatic products with the murata production lines are showing real progress with the growth in IoT and the Ioxus deal has finally provided a range of large cap modules for the market they serve. They now have all the products that have been mentioned over many years and more importantly customers and the market ready to utilise these products. It's just taken longer than expected for the market uptake and a couple of significant events being the murata & Ioxus deals to get to where we are now....right place at the right time with the right products about 5yrs later than expected!

I can only presume that because cpx has failed to deliver over many years that the market won't move the sp until proof of numbers. The problem with AIM though is that the sp can seemingly swing wildly for no apparent reason. I plan to sit tight when the numbers are delivered & wait for what I believe is fair value in the expectation that AIM will play funny games. Might miss a few spikes but expect it to stabilise at a significantly higher value than the current sp. Hope to sell a few once it gets into the 20p's.

I don't think the recent share purchases by certain long standing BoD's is a sign of imminent insolvency. I'm sure the financing conundrum is a tricky area at present let's hope the chosen path is kind to PI's as no doubt securing funds in this market is not going to be easy.
I'm sure there are plenty suitors who at this stage of development would like to take this to market I'm sure we'll get some news soon.

It would be great if cpx could get to a mcap of around 140m which is where nano has fallen back to. Not difficult to see why brokers value cpx currently at 14p and simply wall st at 24p. Both these figures are below what nano is currently worth and cpx are soon to become profitable with growing revenues in a growth market. I know we've being saying it for years but it's only now that the numbers are likely to back-up the forecasts so at some point soon we should see the sp move up significantly

You may well be correct Mer I was referring to pbt but looking at the forecast again they could be ebitda positive. The interim results usually out late Feb could make for some pleasant reading and pave the way for the first significant leg up in sp.

Should read 30th June 2023

I'm not so sure about profit this year up to 30th June 2022 but next year is looking very likely.
If this years results are above expectations then the sp will no doubt shoot up but even a solid set of results inline with expected progress should see a move towards double digits.

Me too but decided to stay the course and continued buying to lower my average and would have several million pre reverse split. You're right about AIM disasters there are many thankfully I've dodged a few bullets whilst watching and deliberating to see companies delist and dissappear such as ctag and dddd. Wasn't so lucky with abdx but decided to cut my losses there as felt it was creating a doom and gloom vibe that was best avoided.
My view here and with some other investments I have made (abdx being an exception) is that as long as they can ride out the volatility and keep going towards their destination at some point they will have their day of glory. Just need a very long term view so that hopefully if you've backed a winner you are fully invested when that day arrives and benefit from significant sp gains. Whether that happens here who knows but the story continues, senior board members continue to buy and they have achieved in the creation of an amazing worlds first technological piece of machinery. That has to have some value that the current sp doesn't recognise so the next phase of accreditation and a little commercial progress could have a significant impact. It might sound crazy but if I'd just encountered this share based on it's perceived no hope share price decline I'd never purchase the amount of shares I currently own but the knowledge gained over many years holding provides a level of understanding that feels less like most other AIM gambles.

That is exactly the case Mer & I like OS have been invested for a long time so have witnessed the missed opportunities. You are quite right that the licensing model meant much of the decision making was out CPX's control. That is no longer the case and CPX will be in direct commercial contact with the customer, a much stronger and informed position to be in. This is not only the case for the Murata products serving a growing IoT market but also with the Ioxus deal they are now in active discussions with customers involved in large supercapacitor modules.
This is a completely different looking company with a growing set of products serving a growth market. Crucially, if the results prove this is happening there should be much to look forwards to with the past disappointments well and truly left behind!

Looking at what's happened to green companies shares this year such as itm, phe, afc and ika with profits years away making raising funds in this climate difficult & expensive you have to say AK has shown great foresight & timing with the murata deal. To be moving into profitability and growing sales in this market is a massive bonus. In time the market will differentiate CPX from those other green technologies which are still some years away from mass adoption. The uptake of supercapacitors is growing rapidly in particular IoT where cpx has market leading products. They also now have a foothold in large capacitor modules with the Ioxus deal and the impact of this could be significant both in terms of sales and profits. There is every chance 2023 could finally see cpx valued to reflect this potential as we hear of the numbers being achieved in the interim & end of year results. GLA to what really should be a prosperous 2023.

Good luck BB hopefully in a few months time any purchase under 25p will be looked back on as being a shrewd investment. I'm still of the opinion this technology is not going to be left to collect dust, how generous the next backer will be is key. Plenty of wealthy individuals who could bank roll this it's just on what terms to appease existing shareholders. At this low level the 25p warrants are looking like an amicable solution although when you've paid around 100p for shares as has been the case for many supporting avo along its journey it's a long way down.

Well to lower my average I purchased just over 80k shares middle of this year for around 23p so looking at these director purchases with a bit of envy as at this price I would have had a much better average. Unfortunately can't put anymore funds here but pleased & somewhat relieved to see these purchases be good to see NS join in. Having said that maybe it would be preferable to participate in a fund raise at 25p then at least avo get the cash.
It might not improve the sp but this is a strong sign everything is continuing as expected towards first patient treatment and accreditation.

Another why not has appeared on the advfn bb with a story about ari6000. It's completely new news to me might be accurate and doesn't look good if true. But you have to ask why bring it up at this late stage to undermine the story. There are people desperately trying to create negativity and not just for fun so I'll take it as a positive that they are making such a big effort which can only be to protect shorters or to accumulate cheap shares.

PS. That's not a claim of some kind of investing genius btw, like most shares I've held it seems well timed trading would of been a better option but I have no idea what causes the spikes and subsequent dips.

I will be thanks. I won't be selling have only ever bought these including in the recent retail offer. Having held watching the rise to 2.80 then fall to 40p I'm well prepared!

It's a bit of a strange one, you don't normally get advance warning of imminent great news and miss the boat. But here we are expecting a major announcement and told it will be early January. The sp is definitely not reacting to what we think will be announced. Imagine where the sp would be if they just issued the actual rns instead of it will be early January.
I'm holding and hoping somehow the market has got this wrong. I've been on the wrong side before maybe this one will work out haven't long to find out GLA especially those who have been here a few years and held all through the covid test saga this really will be redemption!

It's only a token gesture but an important one at that. I think it tells the market the path to first patient treatment & accreditation continues in spite of what the battered sp might lead you to believe

Excellent summary and exactly why I have never sold, accumulated over many years and happy to have a substantial holding going into a transformational 2023. GLA.

It seems the world of science are more impressed with this achievement than the investment community. It's a world first and a major technological milestone that should advance proton therapy treatment. If they can harness the commercial opportunity and it starts to bear fruit then no doubt the investment world will take note as this has the potential to be huge in terms of value. What we need is another £20m or so of funds, around 200m shares including warrants and a clearly communicated plan through to patient treatment and full accreditation. This should include details of expected orders & associated short term revenues via deposits or the unique finance arrangement they have set up, arrangements for manufacturing and a timescale for Harley Street to be up & running. I doubt we'll get all this information but any signs or news of interim progress on any of these points should hopefully result in investor interest. The funding issue is a big one with tons of 25p warrants already issued and the amount needed to get to Q4 2023 and what will be attached to these funds. The market needs to know finances are in place and the number of shares required to achieve this as we're looking at possibly 7 or 800million or more by the end of next year. A view of the size of a growing order book will allow the market to attribute a future value to the shares until then the market can hammer the shares as we are now witnessing as doubt exists in the ability to fund and execute this final phase of the project. Remove the doubt and the sp will be fine.